FLSM
MRUS

Frazier Life Sciences Management’s Merus MRUS Stock Holding History

Frazier Life Sciences Management’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-373,100
Closed -$15.7M – 52
2025
Q1 		$15.7M Hold
373,100
– – 0.72% 27
2024
Q4 		$15.7M Hold
373,100
– – 0.65% 30
2024
Q3 		$18.6M Hold
373,100
– – 0.75% 30
2024
Q2 		$22.1M Sell
373,100
-373,379
-50% -$18.1M 1.03% 25
2024
Q1 		$33.6M Hold
746,479
– – 1.42% 23
2023
Q4 		$20.5M Hold
746,479
– – 1.1% 25
2023
Q3 		$17.6M Hold
746,479
– – 1.17% 20
2023
Q2 		$19.7M Hold
746,479
– – 1.17% 21
2023
Q1 		$13.7M Hold
746,479
– – 0.99% 25
2022
Q4 		$11.5M Hold
746,479
– – 0.72% 27
2022
Q3 		$15M Buy
746,479
+72,500
+11% +$1.73M 1.15% 21
2022
Q2 		$15.3M Buy
673,979
+45,000
+7% +$939K 1.44% 19
2022
Q1 		$16.6M Buy
+628,979
New +$16.9M 1.42% 23

Other funds holding MRUS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return